Pfizer Inc. diskutieren
Pfizer Inc.
WKN: 852009 / Symbol: PFE / Name: Pfizer / Aktie / Pharmazeutika / Large Cap /
21,74 €
-3,40 %
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $45.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) is now covered by analysts at Wolfe Research. They set an "underperform" rating and a $25.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Guggenheim from $35.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Truist Financial Co. from $36.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $33.00 price target on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at HSBC Holdings plc from $35.00 to $27.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Wolfe Research from $25.00 to $22.00. They now have an "underperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Jefferies Financial Group Inc. from $34.00 to $32.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target raised by analysts at Jefferies Financial Group Inc. from $32.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at HSBC Holdings plc from $27.00 to $26.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer Inc. (NYSE: PFE) had its price target raised by analysts at Wolfe Research from $22.00 to $23.00. They now have an "underperform" rating on the stock.
Ratings data for PFE provided by MarketBeat
Pfizer (NYSE:PFE) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for PFE provided by MarketBeat
Pfizer (NYSE:PFE) was upgraded by analysts at Scotiabank to a "strong-buy" rating.
Ratings data for PFE provided by MarketBeat
Pfizer (NYSE:PFE) had its price target raised by analysts at Guggenheim from $33.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat
Neueste Beiträge
BTIG_Research in Workday, Inc. diskutieren